Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein

Fig. 2

Dose-dependent effects on the neutralization of Sfullpv and St19pv infections through sera from convalescent COVID-19 patients. The pseudotyped viruses were preincubated with the indicated dilutions of sera from two different convalescent COVID-19 patients (patients #4 and #7). Thereafter, Vero cells were infected with pseudotyped viruses. Infectivities of pseudotyped viruses were determined by measuring luciferase activities at 24 h post-infection. The results are from three independent assays with error bars representing standard deviations. The significance of any differences in the means was determined using two-way ANOVA. Significance was determined in comparison to the results of the Non serum: *P < 0.1; **P < 0.01; ***P < 0.001; ****P < 0.0001

Back to article page
\